EcoDrugPlus

Chemokine (C-C Motif) Receptor 9a

Ensembl ID : ENSOMYG00000041421
Gene Symbol: CCR9A
2 Cross references
180 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSOMYG00000011008
Gene Symbol: CCKAR
1 Cross references
194 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSOMYG00000023749
Gene Symbol: CCKAR
2 Cross references
194 Possible Orthologues:

Cholecystokinin B Receptor A

Ensembl ID : ENSOMYG00000040754
Gene Symbol: CCKBRA
1 Cross references
183 Possible Orthologues:

Cholecystokinin B Receptor A

Ensembl ID : ENSOMYG00000014028
Gene Symbol: CCKBRA
1 Cross references
187 Possible Orthologues:

Cholesteryl Ester Transfer Protein, Plasma

Ensembl ID : ENSOMYG00000021102
Gene Symbol: CETP
1 Cross references
132 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSOMYG00000031062
Gene Symbol: CHRM3
1 Cross references
180 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSOMYG00000040887
Gene Symbol: CHRM3
1 Cross references
182 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSOMYG00000045561
Gene Symbol: CHRM3
1 Cross references
181 Possible Orthologues:

Cholinergic Receptor Muscarinic 4

Ensembl ID : ENSOMYG00000069588
Gene Symbol: CHRM4
1 Cross references
181 Possible Orthologues:

Cholinergic Receptor Muscarinic 5

Ensembl ID : ENSOMYG00000020178
Gene Symbol: CHRM5
1 Cross references
189 Possible Orthologues:

Cholinergic Receptor Muscarinic 5

Ensembl ID : ENSOMYG00000031687
Gene Symbol: CHRM5
1 Cross references
188 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).